Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis.

Qin, Jiaxuan; Xing, Jinchun; Liu, Rongfu; Chen, Bin; Chen, Yuedong; Zhuang, Xuan

Qin, Jiaxuan; Xing, Jinchun; Liu, Rongfu; Chen, Bin; Chen, Yuedong; Zhuang, Xuan.

Afiliação

Qin J; Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Xing J; Center of Diagnosis and Treatment of Urinary System Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Liu R; The Key Laboratory of Urinary Tract Tumors and Calculi, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Chen B; Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Chen Y; Center of Diagnosis and Treatment of Urinary System Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Zhuang X; The Key Laboratory of Urinary Tract Tumors and Calculi, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.

Oncotarget ; 8(60): 102235-102243, 2017 Nov 24.

Article em En | MEDLINE | ID: mdl-29254239

Palavras-chave

CD40; SNP; immune-related disease; meta-analysis; rs1883832

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google